MIBG With Dinutuximab +/- Vorinostat
Clinical trial NCT03332667 · COMPLETED
Trial details
- NCT number
- NCT03332667
- Sponsor
- New Approaches to Neuroblastoma Therapy Consortium
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-12
- Primary completion
- 2024-02-23
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.